Stock CURE KINARUS THERAPEUTICS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Kinarus Therapeutics Holding AG

Equities

CURE

CH0009115129

Market Closed - Swiss Exchange
Other stock markets
 11:12:24 2024-05-03 am EDT 		5-day change 1st Jan Change
9.754 CHF -15.18% Intraday chart for Kinarus Therapeutics Holding AG -34.97% +444.31%
Apr. 26 Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis MT
Apr. 25 Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction. CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bourse Zurich: le SMI se maintient dans le vert avant l'inflation US
Bourse Zurich: rebond dans les premiers échanges, l'inflation US attendue
Bourse Zurich: un rebond escompté en entame de séance
Kinarus Therapeutics Completes Merger with Unit, Rebrands as Curatis
Curatis (Kinarus) à l'aube de son premier jour de négoce
Curatis AG completed the acquisition of Kinarus Therapeutics Holding AG for CHF 18.3 million in a reverse merger transaction.
Bourse Zurich: les indices effacent une partie des pertes de la veille
Kinarus dévoile son calendrier pour la fusion inversée avec Curatis
Kinarus-Umwandlung in Curatis schreitet voran - erster CURE-Handelstag 26. April
Kinarus: enquête pour violation d'obligation de publication abandonnée
Kinarus: Regulierungsstelle der Börse schliesst Untersuchung gegen Kinarus ab
Kinarus: les actionnaires valident la fusion inversée avec Curatis
Kinarus-Aktionäre genehmigen alle Vorschläge zu Zusammenschluss mit Curatis
En liquidation, Kinarus a réduit sa perte nette l'an dernier
Kinarus mit ungeprüften Jahreszahlen - Zusammenschluss mit Curatis dauert an
Kinarus Therapeutics Receives Swiss Court Approval for Revocation of Bankruptcy
Kinarus: la fusion inversée avec Curatis est prévue d'ici fin juin
Kinarus entkommt dem Konkurs und peilt Zusammenschluss mit Curatis im Q2 an
Kinarus will über Zusammenschluss mit Curatis dem Konkurs entkommen
Kinarus Therapeutics Shares Surge on Combination Deal With Curatis
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CURE Stock
  4. News Kinarus Therapeutics Holding AG
  5. Other languages